Search

Your search keyword '"Hoefele, Julia"' showing total 230 results

Search Constraints

Start Over You searched for: Author "Hoefele, Julia" Remove constraint Author: "Hoefele, Julia" Search Limiters Full Text Remove constraint Search Limiters: Full Text
230 results on '"Hoefele, Julia"'

Search Results

1. Heterozygous variants in MYH10 associated with neurodevelopmental disorders and congenital anomalies with evidence for primary cilia-dependent defects in Hedgehog signaling.

3. Implication of transcription factor FOXD2 dysfunction in syndromic congenital anomalies of the kidney and urinary tract (CAKUT)

4. De novo TRIM8 variants impair its protein localization to nuclear bodies and cause developmental delay, epilepsy, and focal segmental glomerulosclerosis.

5. Correction: Consensus statement on standards and guidelines for the molecular diagnostics of Alport syndrome: refining the ACMG criteria

6. Correction: The 2019 and 2021 International workshops on Alport syndrome

7. Histone H3.3 beyond cancer: Germline mutations in Histone 3 Family 3A and 3B cause a previously unidentified neurodegenerative disorder in 46 patients.

9. Refining Kidney Survival in 383 Genetically Characterized Patients With Nephronophthisis

10. The 2019 and 2021 International Workshops on Alport Syndrome

11. Biallelic and monoallelic variants in PLXNA1 are implicated in a novel neurodevelopmental disorder with variable cerebral and eye anomalies

12. Consensus statement on standards and guidelines for the molecular diagnostics of Alport syndrome: refining the ACMG criteria

13. Correction: Consensus statement on standards and guidelines for the molecular diagnostics of Alport syndrome: refining the ACMG criteria(European Journal of Human Genetics, (2021), 29, 8, (1186-1197), 10.1038/s41431-021-00858-1)

14. Pontocerebellar hypoplasia due to bi-allelic variants in MINPP1

16. Is there a dominant‐negative effect in individuals with heterozygous disease‐causing variants in COL4A3/COL4A4?

17. Genetic Modifiers of Mendelian Monogenic Collagen IV Nephropathies in Humans and Mice

18. IFT74 variants cause skeletal ciliopathy and motile cilia defects in mice and humans

19. Monoallelic intragenic POU3F2 variants lead to neurodevelopmental delay and hyperphagic obesity, confirming the gene’s candidacy in 6q16.1 deletions

20. Abrogation of MAP4K4 protein function causes congenital anomalies in humans and zebrafish

21. Exome sequencing in individuals with congenital anomalies of the kidney and urinary tract (CAKUT): a single-center experience

23. Correction: Consensus statement on standards and guidelines for the molecular diagnostics of Alport syndrome: refining the ACMG criteria

24. Correction: The 2019 and 2021 International workshops on Alport syndrome

25. Implication ofFOXD2dysfunction in syndromic congenital anomalies of the kidney and urinary tract (CAKUT)

26. Renal X-inactivation in female individuals with X-linked Alport syndrome primarily determined by age

27. High detection rate for disease-causing variants in a cohort of 30 Iranian pediatric steroid resistant nephrotic syndrome cases

28. Refining Kidney Survival in 383 Genetically Characterized Patients With Nephronophthisis

29. The multifaceted phenotypic and genotypic spectrum of type-IV-collagen-related nephropathy—A human genetics department experience

30. Refining kidney survival in 383 genetically characterized patients with nephronophthisis

31. Genetics in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

32. Refining Kidney Survival in 383 Genetically Characterized Patients With Nephronophthisis

33. Lifelong effect of therapy in young patients with the COL4A5 Alport missense variant p.(Gly624Asp): a prospective cohort study

34. Guidelines for Genetic Testing and Management of Alport Syndrome

35. KANK deficiency leads to podocyte dysfunction and nephrotic syndrome

36. Correlation of PET-MRI, pathology, LOH and surgical success in a case of CHI with atypical large pancreatic focus

37. Clonal hematopoiesis as a pitfall in germline variant interpretation in the context of Mendelian disorders

38. Lifelong effect of therapy in young patients with the COL4A5 Alport missense variant p.(Gly624Asp): a prospective cohort study

39. Guidelines for Genetic Testing and Management of Alport Syndrome

40. ARHGDIA mutations cause nephrotic syndrome via defective RHO GTPase signaling

41. Blood DNA methylation provides an accurate biomarker of KMT2B-related dystonia and predicts onset

42. Consensus statement on standards and guidelines for the molecular diagnostics of Alport syndrome: refining the ACMG criteria

43. De novo TRIM8 variants impair its protein localization to nuclear bodies and cause developmental delay, epilepsy, and focal segmental glomerulosclerosis

44. Multisystem Inflammation and Susceptibility to Viral infections in Human ZNFX1 Deficiency

45. Precise variant interpretation, phenotype ascertainment, and genotype-phenotype correlation of children in the EARLY PRO-TECT Alport trial

46. Characterization of SETD1A haploinsufficiency in humans and Drosophila defines a novel neurodevelopmental syndrome

47. Renal and Skeletal Anomalies in a Cohort of Individuals With Clinically Presumed Hereditary Nephropathy Analyzed by Molecular Genetic Testing

48. Human exome and mouse embryonic expression data implicateZFHX3,TRPS1, andCHD7in human esophageal atresia

49. De novo variants in neurodevelopmental disorders—experiences from a tertiary care center

50. Heterozygous variants in MYH10associated with neurodevelopmental disorders and congenital anomalies with evidence for primary cilia-dependent defects in Hedgehog signaling

Catalog

Books, media, physical & digital resources